ScoreWhy is CytomX Therapeutics, Inc. ?
1
With a fall in Net Sales of -98.26%, the company declared Very Negative results in Sep 25
- The company has declared negative results in Jan 70 after 2 consecutive negative quarters
- NET SALES(Q) Lowest at USD 5.96 MM
- OPERATING PROFIT(Q) Lowest at USD -15.73 MM
- OPERATING PROFIT MARGIN(Q) Lowest at -263.86 %
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 637.12%, its profits have risen by 101.9%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -3.78% over the previous quarter and currently hold 13.32% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CytomX Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CytomX Therapeutics, Inc.
637.12%
1.02
169.58%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.25%
EBIT Growth (5y)
18.38%
EBIT to Interest (avg)
-30.99
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.98
Sales to Capital Employed (avg)
1.52
Tax Ratio
0.56%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
95.62%
ROCE (avg)
0
ROE (avg)
41.52%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
10.65
EV to EBIT
43.45
EV to EBITDA
41.17
EV to Capital Employed
-32.82
EV to Sales
8.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
26.00%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
ROCE(HY)
Highest at 66.76%
RAW MATERIAL COST(Y)
Fallen by 0.99% (YoY
-28What is not working for the Company
NET SALES(Q)
Lowest at USD 5.96 MM
OPERATING PROFIT(Q)
Lowest at USD -15.73 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -263.86 %
PRE-TAX PROFIT(Q)
Lowest at USD -14.27 MM
NET PROFIT(Q)
Lowest at USD -14.33 MM
EPS(Q)
Lowest at USD -0.09
Here's what is working for CytomX Therapeutics, Inc.
Raw Material Cost
Fallen by 0.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for CytomX Therapeutics, Inc.
Net Sales
At USD 5.96 MM has Fallen at -82.16%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -14.27 MM has Fallen at -346.18%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -14.33 MM has Fallen at -349.81%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Net Sales
Lowest at USD 5.96 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Operating Profit
Lowest at USD -15.73 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -263.86 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD -14.27 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -14.33 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -0.09
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
